These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8670266)

  • 1. Comparison of the effects of calponin and a 38-kDa caldesmon fragment on formation of the "strong-binding" state in ghost muscle fibers.
    Borovikov YS; Khoroshev MI; Chacko S
    Biochem Biophys Res Commun; 1996 Jun; 223(2):240-4. PubMed ID: 8670266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of a caldesmon fragment with a mol. weight of 38 kDa and calponin on the capacity of actin to form a "strong" form of binding with myosin heads].
    Khoroshev MI; Borovikov IuS; Avrova SV; Horiuchi KY; Kirillina VP; Chacko S
    Tsitologiia; 1996; 38(3):346-50. PubMed ID: 8768101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of actin conformation and inhibition of actin filament velocity by calponin.
    Borovikov YuS ; Horiuchi KY; Avrova SV; Chacko S
    Biochemistry; 1996 Oct; 35(43):13849-57. PubMed ID: 8901528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of calponin on smooth and skeletal muscle actomyosin systems in the presence and absence of caldesmon.
    Winder SJ; Sutherland C; Walsh MP
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):733-9. PubMed ID: 1471986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interrelationship between calponin and caldesmon.
    Makuch R; Birukov K; Shirinsky V; Dabrowska R
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):33-8. PubMed ID: 1835840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Caldesmon inhibits formation of strongly bound myosin cross-bridges and activates an ability of weakly bound cross-bridges to transform actin monomers to the off-conformation].
    Vikhorev PG; Vikhoreva NN; Rosliakova MA; Chacko S; Borovikov IuS
    Tsitologiia; 2000; 42(5):444-53. PubMed ID: 10890050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of caldesmon on actin-myosin interaction in skeletal muscle fibers.
    Gałazkiewicz B; Borovikov YS; Dabrowska R
    Biochim Biophys Acta; 1987 Dec; 916(3):368-75. PubMed ID: 3689797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Ca2+-dependent effects of caldesmon-tropomyosin-calmodulin and troponin-tropomyosin complexes on the structure of F-actin in ghost fibers and its interaction with myosin heads.
    Dobrowolski Z; Borovikov YS; Nowak E; Gałazkiewicz B; Dabrowska R
    Biochim Biophys Acta; 1988 Sep; 956(2):140-50. PubMed ID: 3167066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calponin inhibits the strong type of myosin binding with actin].
    Borovikov IuS; Avrova SV; Efimova NN; Khoroshev MI; Choriushi K; Chaco S
    Biokhimiia; 1995 Oct; 60(10):1654-8. PubMed ID: 8555363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Caldesmon and calponin are proteins, participating in the regulation of myosin and actin interaction in nonmuscle and smooth muscle cells].
    Gusev NB; Vorotnikov AV; Biriukov KG; Shirinskiĭ VP
    Biokhimiia; 1991 Aug; 56(8):1347-68. PubMed ID: 1782263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cross-bridge binding to actin by caldesmon fragments in skinned skeletal muscle fibers.
    Heubach JF; Hartwell R; Ledwon M; Kraft T; Brenner B; Chalovich JM
    Biophys J; 1997 Mar; 72(3):1287-94. PubMed ID: 9138574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the relative movement of actin and myosin by caldesmon and calponin.
    Shirinsky VP; Biryukov KG; Hettasch JM; Sellers JR
    J Biol Chem; 1992 Aug; 267(22):15886-92. PubMed ID: 1639818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calponin on actin-activated myosin ATPase activity.
    Abe M; Takahashi K; Hiwada K
    J Biochem; 1990 Nov; 108(5):835-8. PubMed ID: 2150518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caldesmon inhibits skeletal actomyosin subfragment-1 ATPase activity and the binding of myosin subfragment-1 to actin.
    Chalovich JM; Cornelius P; Benson CE
    J Biol Chem; 1987 Apr; 262(12):5711-6. PubMed ID: 2952642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caldesmon and a 20-kDa actin-binding fragment of caldesmon inhibit tension development in skinned gizzard muscle fiber bundles.
    Pfitzer G; Zeugner C; Troschka M; Chalovich JM
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5904-8. PubMed ID: 8327461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the ATP-dependent interaction between actin and myosin by a myosin-binding fragment of smooth muscle caldesmon.
    Lin Y; Ishikawa R; Okagaki T; Ye LH; Kohama K
    Cell Motil Cytoskeleton; 1994; 29(3):250-8. PubMed ID: 7895289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of caldesmon upon interaction of thin filaments with myosin subfragment 1 in ghost fibers.
    Borovikov YS; Wrzosek A; Kulikova N; Vikhorev P; Vikhoreva N; Dabrowska R
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):183-9. PubMed ID: 15158726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the C-terminal actin-binding sites of caldesmon on the interaction of actin with myosin].
    Vikhorev PG; Avrova SV; Ermakov VS; Copeland O; Marston SB; Borovikov IuS
    Tsitologiia; 2000; 42(11):1069-74. PubMed ID: 11204651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomeric binding pattern of exogenously added intact caldesmon and its C-terminal 20-kDa fragment in skinned fibers of skeletal muscle.
    Frisbie SM; Reedy MC; Yu LC; Brenner B; Chalovich JM; Kraft T
    J Muscle Res Cell Motil; 1999 Apr; 20(3):291-303. PubMed ID: 10471992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caldesmon inhibits both force development and transition of actin monomers from "OFF" to "ON" conformational state by changing its position in thin filaments.
    Pronina OE; Makuch R; Wrzosek A; Dabrowska R; Borovikov YS
    Cell Biol Int; 2007 Apr; 31(4):394-404. PubMed ID: 17321764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.